No personal data (including your IP address) is stored, nor do we sell data to third parties.
Lisbon – With the Global Futures Forum just weeks away, we are announcing our full line-up of Disruptors, including post-chemical pharmacy Biocol Labs.
Biocol Labs designs products that appeal to today’s Optimisers, who are more informed than ever about what they put into their bodies. We are including the firm in the line-up for our Disruptors’ Labyrinth to demonstrate that a fresh mindset can shake up even the most corporate and traditional of industries, such as the pharmaceutical sector.
Biocol’s transparent, design-led approach that focuses on ingredients serves as a backlash against Big Pharma, and highlights how it values its creative collaborators as much as its team of scientists. ‘The traditional healthcare industry has very strictly defined channels. We are opening up those channels and want to be where our clients are, online and offline,’ Christine Pausewang, head of global brand management at Biocol Labs, tells LS:N Global.
By aligning itself to the wellness industry, Biocol Labs is tapping into a £2.3 trillion ($3.4 trillion, €3 trillion) market that outpaces the pharmaceutical sector in terms of sales figures, according to the Global Wellness Institute.
For more details on the Global Futures Forum and a full itinerary of the keynote speeches, insight presentations and strategic workshops available to attendees, visit the Global Futures Forum site.